6.17am EDT06:17
Poll – only 12% of US adults rate Covid as a top national priority, even as more than 1,000 die daily
4.34am EDT04:34
Germany reports highest daily caseload since start of pandemic
Updated
at 4.45am EDT
4.17am EDT04:17
Vaccine certificates-for-sale scam undermines Lesotho’s Covid effort
The Lesotho government’s plans to implement a Covid passport system this week are being undermined by widespread fraud involving certificates being sold to unvaccinated people.
Covid-19 vaccination certificates are being sold for less than £20 by unscrupulous health workers to the largely vaccine-averse population in Lesotho, where there has been little positive campaigning around the jabs.
The prime minister, Moeketsi Majoro, announced in October that from this week, restaurants, bars, nightclubs, gyms and sporting facilities would only admit people who had a Covid-19 vaccination certificate.
It led to an immediate increase in the numbers presenting for vaccination, with queues at health centres, but has also sparked a burgeoning hidden market in fraudulent certificates.
The latest scam follows a reported jabs-for-cash scandal involving health workers from Motebang hospital in Leribe, about 50 miles north-east of the capital, Maseru. The health workers allegedly sold Covid-19 jabs to ineligible people, among them expatriates, for about £19, during a period when the government was still vaccinating frontline workers and vulnerable people.
Read more of Silence Charumbira’s report from Maseru: Vaccine certificates-for-sale scam undermines Lesotho’s Covid effort
2.35am EDT02:35
WHO approves Indian-made Covaxin vaccine
After months of delay, the World Health Organisation (WHO) has finally given emergency approval to Covaxin, the Indian domestically developed Covid vaccine which was rolled out as part of India’s vaccination drive.
The approval is good news for Indian travellers who received the vaccine, as it will now be recognised to allow entry into countries such as the US.
“The Technical Advisory Group, convened by WHO and made up of regulatory experts from around the world, has determined that the #Covaxin vaccine meets WHO standards for protection against #COVID19, that the benefit of the vaccine far outweighs risks & the vaccine can be used across the planet,” tweeted WHO on Wednesday.
The decision by the Indian government back in January to begin administering Covaxin, developed by Indian pharmaceutical company Bharat Biotech, was initially mired in controversy over concerns it was being rolled out before all the efficacy data had been released.
It was administered in much smaller quantities than AstraZeneca, the only other approved vaccine in India. Figures from September show that Covaxin accounted for just over 12% of jabs in India.
Data released in July showed that Covaxin has an efficacy of 77.8% against Covid.
On Wednesday, health minister Mansukh Mandaviya tweeted: “This is a sign of a capable leadership. This is the story of Modi ji’s resolve. This is the language of the faith of the countrymen. This is a Diwali of self-reliant India. Thanking @WHO for granting emergency use listing (EUL) to Made-in-India #Covaxin,.”